Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Companies

GE And Roche Join Forces In First-Of-Its-Kind Tech Pact

The goliaths of imaging and in vitro diagnostics have sealed a pact to codevelop a new data analytics platform for faster clinical decision-making, more accurate diagnosis and more personalized treatments.

Diagnostic Imaging In Vitro Diagnostics Deals

Latest From Companies

QUOTED. Jan. 17, 2018. Ariel Weinstein.

Check out what OCON Medical CEO Ariel Weinstein had to say about his company's efforts to leverage its "intrauterine ball" hormone-free contraceptive platform for future pipeline projects.
Commercial Companies

Start-Up Spotlight: OCON Medical Bets On A New 3D Copper Contraceptive Device

Israeli start-up OCON Medical is blazing a trail in the field of women's health with a new hormone-free contraceptive device. The company's IUB – intrauterine ball consists of copper pearls that prevent pregnancy locally within the uterus for five years.

Start-up Spotlight Commercial

QUOTED. Jan. 12, 2018. Raymond Cohen.

Check out who Axonics Modulation Technologies CEO Raymond Cohen says would make up his dream team to take the company’s technology from bench to market.
Quoted Business Strategies

Philips' Ultrasound Head Takes Over North Am Unit

Vitor Rocha, head of Philips' global ultrasound business, has taken over from Brent Shafer as CEO of Philips North America.

Appointments Companies

JPM2018: $15bn Market Opp Awaits Boston Scientific, Forecasts Mahoney

Boston Scientific CEO and chairman Mike Mahoney provided a positive preliminary Q4 earnings outlook during his presentation at the JP Morgan HealthCare Conference on Jan. 9, and outlined plans for the medical device giant's growth for 2018 and beyond, including a $15bn market opportunity between 2018 and 2021.

Sales & Earnings Companies

Illumina, Varian Among Flurry Of China Collabs

The ever-growing importance of the Chinese market and the increasing presence of Chinese players in the global medtech arena has not gone amiss in 2017, and the new year began with a flurry of announcements of further East-West partnerships being forged, including one by next-gen sequencing leader Illumina and by cancer therapy specialist Varian Medical Systems. Additionally, global investment firm Ally Bridge sealed a deal with LifeTech to co-invest in medtech companies looking to tackle China.

China Cancer

QUOTED. Jan. 10, 2018. Ian Gilham.

Check out what Ian Gilham, an IVD industry veteran and former CEO of Axis-Shield, had to say about how medical device firms can pick themselves back up after product or manufacturing problems strike.
Quoted Business Strategies

JPM2018: Nevro Announces FDA Nod For Next-Gen Senza II Device

Redwood City, Calif.-based device-maker Nevro Corp. kicked off the annual J.P. Morgan Healthcare Conference in San Francisco on Jan. 8 with the announcement it received US FDA approval for its next-generation Senza II spinal cord stimulation system and better-than-expected Q4 earnings results.

FDA Approvals

M&A Analysis: M&A Rises In 2017 As Market Set To Bounce Back In 2018

2017 proved to be a busy year for medtech M&A activity, with the number of deals rising from 174 in 2016, to 206 in 2017. The year also brought a number of notable acquisitions, including Becton Dickinson's blockbuster $24bn purchase of CR Bard and Dutch health-care giant Philips undertaking an ambitious acquisition spree. Medtech Insight takes a look at the highlights of 2017 and what's in store for 2018.

M & A Deals
See All